Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coactivator activity	ASXL1 KAT6A ZMIZ1 DCC BCL9 KMT2D TAF5L TRIM37 EP300	6.98e-05	303	116	9	GO:0003713
GeneOntologyMolecularFunction	transcription coregulator activity	ASXL1 KAT6A BCORL1 NFKBIZ ZMIZ1 DCC BCL9 BCOR KMT2D TAF5L TRIM37 EP300	1.06e-04	562	116	12	GO:0003712
GeneOntologyBiologicalProcess	heart development	ASXL1 RPGRIP1L RARB KAT6A DVL2 ZMIZ1 BCOR RBM20 FREM2 ADRA1B FBN1 ZFP36L1 GLI2 GYS1 CACNA1G EP300	6.57e-06	757	118	16	GO:0007507
GeneOntologyBiologicalProcess	negative regulation of chondrocyte differentiation	RARB RARG GLI2 MKX	1.61e-05	27	118	4	GO:0032331
GeneOntologyBiologicalProcess	developmental growth	SOX10 RARB RARG APBA2 LAMB2 ZMIZ1 DCC BCL9 ECM1 ADRA1B KMT2D LATS2 ZFP36L1 GLI2 COBL ULK2 EP300	1.68e-05	911	118	17	GO:0048589
GeneOntologyBiologicalProcess	cellular response to hormone stimulus	SOX10 ASXL1 ZNF536 RARB RARG TRARG1 ZMIZ1 FGF23 FAT1 KMT2D FBN1 LATS2 ZFP36L1 NFE2L2 EP300	1.74e-05	727	118	15	GO:0032870
GeneOntologyBiologicalProcess	embryo development	SOX10 RPGRIP1L RARB RARG KAT6A DVL2 APBA2 ZMIZ1 BCOR FREM2 KMT2D HOXC5 SALL2 LATS2 ZFP36L1 NFE2L2 GLI2 COBL DLX3 TNFAIP3 EP300 RAI2	1.94e-05	1437	118	22	GO:0009790
GeneOntologyBiologicalProcess	circulatory system development	JCAD ASXL1 RPGRIP1L RARB KAT6A DVL2 ZMIZ1 BCOR ECM1 RBM20 FREM2 ADRA1B FBN1 ZFP36L1 NFE2L2 GLI2 GYS1 MMRN2 CACNA1G DLX3 TNFAIP3 EP300	2.05e-05	1442	118	22	GO:0072359
GeneOntologyBiologicalProcess	growth	MAPKAP1 SOX10 RARB RARG APBA2 LAMB2 NFKBIZ ZMIZ1 DCC BCL9 ARHGEF11 ECM1 ADRA1B KMT2D LATS2 ZFP36L1 GLI2 COBL ULK2 EP300	2.22e-05	1235	118	20	GO:0040007
GeneOntologyBiologicalProcess	intracellular receptor signaling pathway	ASXL1 ZNF536 RARB RARG PELI1 ZMIZ1 SIRT2 KMT2D ZDHHC9 TNFAIP3 EP300	2.73e-05	416	118	11	GO:0030522
GeneOntologyBiologicalProcess	chromosome organization	TPR RTEL1 KAT6A MCM4 PPHLN1 ESCO1 GOLGA8N GOLGA8M SIRT2 NAT10 YLPM1 XRN1 TNKS1BP1 KIF18B	3.81e-05	686	118	14	GO:0051276
GeneOntologyBiologicalProcess	negative regulation of cartilage development	RARB RARG GLI2 MKX	5.20e-05	36	118	4	GO:0061037
GeneOntologyBiologicalProcess	retinoic acid receptor signaling pathway	ASXL1 ZNF536 RARB RARG	6.46e-05	38	118	4	GO:0048384
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	SOX10 RPGRIP1L RARG DVL2 APBA2 ZMIZ1 BCOR KMT2D HOXC5 SALL2 LATS2 ZFP36L1 GLI2 COBL EP300 RAI2	7.89e-05	929	118	16	GO:0009792
GeneOntologyBiologicalProcess	hormone-mediated signaling pathway	ASXL1 ZNF536 RARB RARG ZMIZ1 KMT2D LATS2 EP300	8.17e-05	244	118	8	GO:0009755
GeneOntologyBiologicalProcess	spinal cord ventral commissure morphogenesis	DCC GLI2	9.70e-05	3	118	2	GO:0021965
GeneOntologyBiologicalProcess	negative regulation of cell differentiation	SOX10 ASXL1 ZNF536 RARB RARG BICRA DCC FGF23 SIRT2 FBN1 ZFP36L1 NFE2L2 GLI2 MKX ULK2	1.41e-04	875	118	15	GO:0045596
GeneOntologyBiologicalProcess	neural tube development	RPGRIP1L RARG DVL2 SALL2 ZFP36L1 GLI2 COBL	1.64e-04	202	118	7	GO:0021915
GeneOntologyBiologicalProcess	nuclear receptor-mediated signaling pathway	ASXL1 ZNF536 RARB RARG ZMIZ1 KMT2D EP300	1.64e-04	202	118	7	GO:0141193
GeneOntologyBiologicalProcess	negative regulation of ossification	BCOR ECM1 FGF23 MKX	1.91e-04	50	118	4	GO:0030279
GeneOntologyBiologicalProcess	chordate embryonic development	SOX10 RPGRIP1L RARG DVL2 APBA2 ZMIZ1 BCOR KMT2D HOXC5 SALL2 LATS2 ZFP36L1 GLI2 COBL EP300	2.06e-04	906	118	15	GO:0043009
GeneOntologyBiologicalProcess	epithelium development	SOX10 ASXL1 RPGRIP1L RARB RARG DVL2 LAMB2 NFKBIZ PPHLN1 FREM2 FAT1 OVOL1 SALL2 LATS2 ZFP36L1 GLI2 MMRN2 COBL DLX3 EP300	2.41e-04	1469	118	20	GO:0060429
GeneOntologyBiologicalProcess	kidney development	COL4A4 ASXL1 RPGRIP1L RARB LAMB2 FREM2 FBN1 OVOL1 GLI2	2.91e-04	372	118	9	GO:0001822
GeneOntologyBiologicalProcess	response to hormone	SOX10 ASXL1 ZNF536 RARB RARG TRARG1 ZMIZ1 FGF23 ADRA1B FAT1 KMT2D FBN1 LATS2 ZFP36L1 NFE2L2 EP300	2.93e-04	1042	118	16	GO:0009725
GeneOntologyBiologicalProcess	negative regulation of bone mineralization	BCOR ECM1 FGF23	2.97e-04	23	118	3	GO:0030502
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	TPR SOX10 ZNF536 RARB RARG BCORL1 BCOR SIRT2 OVOL1 SALL2 GLI2 YLPM1 MKX MAGEC1 TRIM37 EP300	3.29e-04	1053	118	16	GO:0000122
GeneOntologyBiologicalProcess	developmental cell growth	RARG LAMB2 DCC ADRA1B KMT2D COBL ULK2 EP300	3.42e-04	301	118	8	GO:0048588
GeneOntologyBiologicalProcess	regulation of chondrocyte differentiation	RARB RARG GLI2 MKX	3.63e-04	59	118	4	GO:0032330
GeneOntologyBiologicalProcess	tube development	SOX10 JCAD ASXL1 RPGRIP1L RARB RARG KAT6A DVL2 ZMIZ1 ECM1 FBN1 SALL2 ZFP36L1 NFE2L2 GLI2 MMRN2 COBL TNFAIP3 EP300	3.73e-04	1402	118	19	GO:0035295
GeneOntologyBiologicalProcess	renal system development	COL4A4 ASXL1 RPGRIP1L RARB LAMB2 FREM2 FBN1 OVOL1 GLI2	3.81e-04	386	118	9	GO:0072001
GeneOntologyBiologicalProcess	protein acylation	KAT6A ESCO1 ZDHHC9 NAT10 EP300	3.92e-04	108	118	5	GO:0043543
GeneOntologyBiologicalProcess	regulation of DNA metabolic process	RTEL1 PELI1 MCM4 ESCO1 GLI2 NAT10 YLPM1 XRN1 TAF5L IL27RA NPAS2	3.96e-04	564	118	11	GO:0051052
GeneOntologyBiologicalProcess	Golgi organization	GOLGA8T GOLGA8Q GOLGA8N GOLGA8IP GOLGA8M RBSN	4.15e-04	168	118	6	GO:0007030
GeneOntologyBiologicalProcess	negative regulation of autophagy	GOLGA8N GOLGA8M SIRT2 TNFAIP3 EP300	4.64e-04	112	118	5	GO:0010507
GeneOntologyBiologicalProcess	cartilage development	RARB RARG UNCX ECM1 GLI2 MKX EP300	5.03e-04	243	118	7	GO:0051216
GeneOntologyBiologicalProcess	negative regulation of developmental process	SOX10 ASXL1 ZNF536 RARB RARG BICRA DCC BCOR ECM1 FGF23 SIRT2 FBN1 ZFP36L1 NFE2L2 GLI2 MKX ULK2	5.72e-04	1220	118	17	GO:0051093
GeneOntologyBiologicalProcess	regulation of myelination	SOX10 RARB RARG SIRT2	5.91e-04	67	118	4	GO:0031641
GeneOntologyBiologicalProcess	regulation of stem cell proliferation	RARB RARG OVOL1 ZFP36L1 GLI2	6.12e-04	119	118	5	GO:0072091
GeneOntologyBiologicalProcess	protein acetylation	KAT6A ESCO1 NAT10 EP300	6.25e-04	68	118	4	GO:0006473
GeneOntologyCellularComponent	Golgi cis cisterna	GOLGA8T GOLGA8Q GOLGA8N GOLGA8IP GOLGA8M	1.10e-06	33	118	5	GO:0000137
GeneOntologyCellularComponent	cis-Golgi network	GOLGA8T BCL9 GOLGA8Q GOLGA8N GOLGA8IP GOLGA8M	8.66e-06	85	118	6	GO:0005801
GeneOntologyCellularComponent	cytoplasmic ribonucleoprotein granule	POLR2G NFKBIZ RBM20 ZFP36L1 XRN1 OGFOD1 TAF5L PPP6R2	1.46e-04	269	118	8	GO:0036464
GeneOntologyCellularComponent	Golgi cisterna membrane	GOLGA8T GOLGA8Q GOLGA8N GOLGA8IP GOLGA8M	1.94e-04	94	118	5	GO:0032580
GeneOntologyCellularComponent	ribonucleoprotein granule	POLR2G NFKBIZ RBM20 ZFP36L1 XRN1 OGFOD1 TAF5L PPP6R2	2.27e-04	287	118	8	GO:0035770
GeneOntologyCellularComponent	basement membrane	COL4A4 LAMB2 FREM2 FBN1 MMRN2	6.45e-04	122	118	5	GO:0005604
GeneOntologyCellularComponent	Golgi cisterna	GOLGA8T GOLGA8Q GOLGA8N GOLGA8IP GOLGA8M	1.02e-03	135	118	5	GO:0031985
HumanPheno	Tooth agenesis	SOX10 POLR1A RTEL1 KAT6A DCC BCOR KMT2D GLI2 PACS2 DLX3 TRIM37 EP300	2.90e-05	363	43	12	HP:0009804
HumanPheno	Pectus excavatum	SOX10 ASXL1 BICRA KAT6A BCORL1 ZMIZ1 BCOR FBN1 ZDHHC9 MYPN EP300	5.15e-05	323	43	11	HP:0000767
HumanPheno	Coloboma	ASXL1 RPGRIP1L POLR1A ZMIZ1 BCOR KMT2D SALL2 GLI2 TRIM37 EP300	6.78e-05	274	43	10	HP:0000589
HumanPheno	Lateral ventricular asymmetry	FBN1 GLI2	6.96e-05	2	43	2	HP:0100960
HumanPheno	Abnormal nasolacrimal system morphology	SOX10 KAT6A FREM2 KMT2D GLI2 EP300	7.66e-05	87	43	6	HP:0000614
HumanPheno	Abnormal cheek morphology	ASXL1 RPGRIP1L BICRA KAT6A BCOR KMT2D FBN1 ELMO2 GLI2 EP300	8.65e-05	282	43	10	HP:0004426
HumanPheno	Optic disc coloboma	RPGRIP1L BCOR KMT2D SALL2	8.97e-05	29	43	4	HP:0000588
HumanPheno	Low hanging columella	BICRA KAT6A ZMIZ1 KMT2D EP300	9.38e-05	56	43	5	HP:0009765
HumanPheno	Abnormality of the helix	BICRA KAT6A ZMIZ1 BCOR KMT2D FBN1 GLI2 EP300	1.17e-04	183	43	8	HP:0000380
HumanPheno	Abnormal number of teeth	SOX10 POLR1A RTEL1 KAT6A DCC BCOR KMT2D GLI2 PACS2 DLX3 TRIM37 EP300	1.25e-04	421	43	12	HP:0006483
HumanPheno	Prominent nasal bridge	SOX10 RPGRIP1L POLR1A BICRA KAT6A ZMIZ1 BCOR FBN1 ZDHHC9	1.32e-04	239	43	9	HP:0000426
HumanPheno	Anteverted ears	KAT6A BCOR CACNA1G	1.91e-04	14	43	3	HP:0040080
HumanPheno	Dysmyelinating leukodystrophy	SOX10 DARS2	2.08e-04	3	43	2	HP:0006978
HumanPheno	Abnormal conjugate eye movement	ASXL1 RPGRIP1L POLR1A BICRA KAT6A BCORL1 LAMB2 ZMIZ1 DCC BCOR ADD3 KMT2D FBN1 SALL2 ZDHHC9 MRPS2 GLI2 PACS2 CACNA1G TRIM37 EP300	2.43e-04	1198	43	21	HP:0000549
HumanPheno	Abnormality of the incisor	KAT6A BCOR GLI2 PACS2 DLX3 EP300	2.55e-04	108	43	6	HP:0000676
HumanPheno	Agenesis of incisor	KAT6A BCOR GLI2 DLX3	2.64e-04	38	43	4	HP:0006485
HumanPheno	Anophthalmia	RPGRIP1L RARB BCOR FREM2 GLI2	2.72e-04	70	43	5	HP:0000528
HumanPheno	Prominent antihelix	BICRA KAT6A GLI2	2.91e-04	16	43	3	HP:0000395
HumanPheno	Intestinal malrotation	ASXL1 RARB KAT6A BCOR FREM2 KMT2D EP300	2.93e-04	157	43	7	HP:0002566
HumanPheno	Abnormal helix morphology	BICRA KAT6A ZMIZ1 BCOR KMT2D FBN1 GLI2 EP300	3.24e-04	212	43	8	HP:0011039
HumanPheno	Abnormal sternum morphology	SOX10 ASXL1 BICRA KAT6A BCORL1 ZMIZ1 BCOR FBN1 ZDHHC9 ELMO2 MYPN EP300	3.83e-04	474	43	12	HP:0000766
HumanPheno	Hyperdeviation	FBN1 SALL2	4.13e-04	4	43	2	HP:0025587
HumanPheno	Hypertropia	FBN1 SALL2	4.13e-04	4	43	2	HP:0025586
HumanPheno	Abnormality of lens shape	COL4A4 LAMB2 FBN1	4.19e-04	18	43	3	HP:0011526
HumanPheno	Bicuspid aortic valve	POLR1A BCOR KMT2D FBN1 NFE2L2 EP300	4.31e-04	119	43	6	HP:0001647
HumanPheno	Abnormality of globe location or size	TPR ASXL1 RPGRIP1L RARB POLR1A BICRA KAT6A BCORL1 LAMB2 ZMIZ1 BCOR FREM2 KMT2D FBN1 ELMO2 GLI2 MYPN PACS2 CACNA1G TRIM37 EP300	4.34e-04	1246	43	21	HP:0000489
MousePheno	abnormal heart atrium morphology	RPGRIP1L KAT6A ZMIZ1 RBM20 FREM2 FBN1 LATS2 GYS1 MYPN EP300	6.70e-06	232	101	10	MP:0003105
MousePheno	abnormal tendon sheath morphology	FBN1 MKX	5.17e-05	2	101	2	MP:0030799
MousePheno	absent metoptic pillar	RARB RARG	5.17e-05	2	101	2	MP:0010705
Domain	PUFD	BCORL1 BCOR	3.82e-05	2	116	2	IPR032365
Domain	PUFD	BCORL1 BCOR	3.82e-05	2	116	2	PF16553
Domain	BCOR	BCORL1 BCOR	3.82e-05	2	116	2	PF15808
Domain	BCOR	BCORL1 BCOR	3.82e-05	2	116	2	IPR031628
Domain	Retinoic_acid_rcpt	RARB RARG	2.28e-04	4	116	2	IPR003078
Pubmed	Human transcription factor protein interaction networks.	VAPA SOX10 ASXL1 ZNF536 DNAH10 MRPS18B BICRA BCORL1 ZMIZ1 BCL9 BCOR RBM20 FAT1 KMT2D FBN1 SALL2 MRPS2 GLI2 NAT10 YLPM1 XRN1 MRTO4 TAF5L EP300 RAI2	1.44e-11	1429	119	25	35140242
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TPR ZNF536 BCORL1 DVL2 ZMIZ1 BCOR RBM20 KMT2D TOX4 SALL2 FAM193A XRN1 TNKS1BP1	2.24e-09	418	119	13	34709266
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	RARG BICRA KAT6A SLCO4A1 LAMB2 BCL9 ARHGEF11 FAT1 SIRT2 KMT2D OVOL1 LATS2 COBL TNKS1BP1 TNFAIP3 ULK2 EP300 AGAP3	4.26e-08	1105	119	18	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF536 BICRA KAT6A DVL2 APBA2 CHD9 DCAF16 BCOR FAT1 SALL2 FAM120C NAT10 XRN1 TAF5L KIF18B EP300 AGAP3	2.70e-07	1116	119	17	31753913
Pubmed	Retinoic acid receptors exhibit cell-autonomous functions in cranial neural crest cells.	SOX10 RARB RARG	2.16e-06	8	119	3	19777591
Pubmed	A census of human transcription factors: function, expression and evolution.	SOX10 RARB RARG UNCX KMT2D TOX4 HOXC5 SALL2 ZFP36L1 NFE2L2 GLI2 MKX DLX3 NPAS2	2.90e-06	908	119	14	19274049
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	POLR1A RTEL1 BICRA KAT6A CHD9 PPHLN1 ZMIZ1 ESCO1 LATS2 FAM120C PLEKHG3 GLI2 NAT10 COBL AFF1 EP300 AGAP3 NPAS2	3.21e-06	1489	119	18	28611215
Pubmed	Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair.	RARB RARG EP300	3.23e-06	9	119	3	21722948
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	RPGRIP1L BCOR KMT2D FBN1 FAM193A XRN1 TRIM37	3.52e-06	184	119	7	32908313
Pubmed	Interaction network of human early embryonic transcription factors.	ZNF536 BICRA BCORL1 ZMIZ1 BCL9 BCOR KMT2D TAF5L EP300	3.58e-06	351	119	9	38297188
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	TPR ZMIZ1 BCL9 BCOR RBM20 KMT2D MRPS2 YLPM1 XRN1 EP300	4.13e-06	457	119	10	32344865
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	SOX10 DNAH10 KAT6A PELI1 GGTLC2 ACSL3 LATS2 PCSK7 KCNS1 TAF5L ULK2 EP300	8.18e-06	730	119	12	34857952
Pubmed	Isolation and developmental expression of retinoic-acid-induced genes.	RARB RARG RAI2	8.40e-06	12	119	3	8314004
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	JCAD BICRA BCORL1 BCOR RBM20 KMT2D TAF5L EP300 RAI2	9.82e-06	398	119	9	35016035
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	ZNF536 BCL9 BCOR KMT2D EP300	1.01e-05	83	119	5	28794006
Pubmed	The SIRT2 deacetylase regulates autoacetylation of p300.	SIRT2 EP300	1.16e-05	2	119	2	18995842
Pubmed	Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes.	SIRT2 EP300	1.16e-05	2	119	2	29262808
Pubmed	[Clinical Characteristics and Prognostic Significance of BCOR/BCORL1 Gene Mutation in Patients with Myelodysplastic Syndromes].	BCORL1 BCOR	1.16e-05	2	119	2	33283733
Pubmed	Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs.	FBN1 TNFAIP3	1.16e-05	2	119	2	36289219
Pubmed	Quantification and localization of expression of the retinoic acid receptor-beta and -gamma mRNA isoforms during neurulation in mouse embryos with or without spina bifida.	RARB RARG	1.16e-05	2	119	2	12486767
Pubmed	Effect of DNA methylation profile on OATP3A1 and OATP4A1 transcript levels in colorectal cancer.	SLCO4A1 SLCO3A1	1.16e-05	2	119	2	26349991
Pubmed	Specific spatial and temporal distribution of retinoic acid receptor gamma transcripts during mouse embryogenesis.	RARB RARG	1.16e-05	2	119	2	2161730
Pubmed	Muscle cell survival mediated by the transcriptional coactivators p300 and PCAF displays different requirements for acetyltransferase activity.	TAF5L EP300	1.16e-05	2	119	2	16672693
Pubmed	A retinoic acid receptor beta/gamma-selective prodrug (tazarotene) plus a retinoid X receptor ligand induces extracellular signal-regulated kinase activation, retinoblastoma hypophosphorylation, G0 arrest, and cell differentiation.	RARB RARG	1.16e-05	2	119	2	15383624
Pubmed	MOZ is fused to p300 in an acute monocytic leukemia with t(8;22).	KAT6A EP300	1.16e-05	2	119	2	10824998
Pubmed	MCM4 potentiates evasion of hepatocellular carcinoma from sorafenib-induced ferroptosis through Nrf2 signaling pathway.	MCM4 NFE2L2	1.16e-05	2	119	2	39276458
Pubmed	Age-Related Co-Expression of BCOR and BCORL1 mRNA in Acute Myeloid Leukemia.	BCORL1 BCOR	1.16e-05	2	119	2	32776737
Pubmed	JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.	JCAD LATS2	1.16e-05	2	119	2	28775168
Pubmed	Gene mutation profile in patients with acquired pure red cell aplasia.	BCORL1 BCOR	1.16e-05	2	119	2	32594217
Pubmed	Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.	BCORL1 BCOR	1.16e-05	2	119	2	35499168
Pubmed	SIRT2 inhibition protects against cardiac hypertrophy and ischemic injury.	SIRT2 NFE2L2	1.16e-05	2	119	2	37728319
Pubmed	BCOR and BCORL1 mutations in pediatric acute myeloid leukemia.	BCORL1 BCOR	1.16e-05	2	119	2	25596268
Pubmed	Sirtuin 2 regulates cellular iron homeostasis via deacetylation of transcription factor NRF2.	SIRT2 NFE2L2	1.16e-05	2	119	2	28287409
Pubmed	BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes.	BCORL1 BCOR	1.16e-05	2	119	2	35015684
Pubmed	BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.	BCORL1 BCOR	1.16e-05	2	119	2	24047651
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CHD9 SALL2 ELMO2 TMEM131 TRIM37	1.27e-05	87	119	5	12465718
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	MAPKAP1 POLR2G DVL2 PNISR GPATCH2L ADD3 SIRT2 ZFP36L1 GYS1 MYPN XRN1 TNKS1BP1 PPP6R2 TRIM37	1.32e-05	1038	119	14	26673895
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR SLCO4A1 MCM4 BCL9 BCOR PNISR ACSL3 KMT2D YLPM1 PACS2 AFF1 TNKS1BP1	1.46e-05	774	119	12	15302935
Pubmed	GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules.	BCL9 GOLGA8N GOLGA8M	1.72e-05	15	119	3	26165940
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	JCAD BICRA BCL9 TMEM132C FAM193A NFE2L2 GLI2 YLPM1 AFF1	1.81e-05	430	119	9	35044719
Pubmed	Congenital Diaphragmatic Hernia Overview	RARB FREM2 KMT2D FBN1	1.90e-05	46	119	4	20301533
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TPR DVL2 MCM4 BCOR ADD3 SIRT2 TOX4 FAM193A NAT10 YLPM1 XRN1 TNKS1BP1 PPP6R2	1.97e-05	934	119	13	33916271
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ASXL1 KAT6A MCM4 FAT1 TOX4 TNKS1BP1 MTCL1 EP300	1.98e-05	332	119	8	37433992
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TPR BCOR ADD3 KMT2D TOX4 NAT10 YLPM1 XRN1 TNKS1BP1 EP300	2.02e-05	549	119	10	38280479
Pubmed	Enhancer Variants Synergistically Drive Dysfunction of a Gene Regulatory Network In Hirschsprung Disease.	SOX10 RARB RARG	2.12e-05	16	119	3	27693352
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	DARS2 KMT2D TOX4 YIF1B FAM120C YLPM1 TNKS1BP1 MRTO4	2.40e-05	341	119	8	32971831
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	COL4A4 LAMB2 ECM1 FREM2 FBN1 MMRN2	2.48e-05	167	119	6	22159717
Pubmed	Yip1B isoform is localized at ER-Golgi intermediate and cis-Golgi compartments and is not required for maintenance of the Golgi structure in skeletal muscle.	GOLGA8N GOLGA8M YIF1B	3.07e-05	18	119	3	25208654
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SOX10 ZNF536 RARB RARG RBSN TOX4 HOXC5 OVOL1 SALL2 GLI2 MKX	3.36e-05	709	119	11	22988430
Pubmed	Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants.	RARB RARG	3.47e-05	3	119	2	7607068
Pubmed	Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants.	RARB RARG	3.47e-05	3	119	2	7607067
Pubmed	Impaired distribution of retinoic acid receptors in the hindgut-tailgut region of murine embryos with anorectal malformations.	RARB RARG	3.47e-05	3	119	2	11172439
Pubmed	Cloning of several genes coding for retinoic acid nuclear receptors in the mouse embryonal carcinoma cell line PCC7-MZ1.	RARB RARG	3.47e-05	3	119	2	8383767
Pubmed	Retinoic acid receptor gamma: specific immunodetection and phosphorylation.	RARB RARG	3.47e-05	3	119	2	1655807
Pubmed	Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response.	NFE2L2 EP300	3.47e-05	3	119	2	19273602
Pubmed	Contribution of retinoic acid receptor beta isoforms to the formation of the conotruncal septum of the embryonic heart.	RARB RARG	3.47e-05	3	119	2	9659935
Pubmed	Altered expression of retinoic acid (RA) receptor mRNAs in the fetal mouse secondary palate by all-trans and 13-cis RAs: implications for RA-induced teratogenesis.	RARB RARG	3.47e-05	3	119	2	10100049
Pubmed	Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues.	RARB RARG	3.47e-05	3	119	2	1283441
Pubmed	The KDM6A-KMT2D-p300 axis regulates susceptibility to diverse coronaviruses by mediating viral receptor expression.	KMT2D EP300	3.47e-05	3	119	2	37410700
Pubmed	Synergistic activation of RARβ and RARγ nuclear receptors restores cell specialization during stem cell differentiation by hijacking RARα-controlled programs.	RARB RARG	3.47e-05	3	119	2	36446525
Pubmed	Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes.	RARB RARG	3.47e-05	3	119	2	1655630
Pubmed	Immunolocalization of retinoic acid receptors in rat, mouse and human ovary and uterus.	RARB RARG	3.47e-05	3	119	2	8136307
Pubmed	The acetyltransferase p300 regulates NRF2 stability and localization.	NFE2L2 EP300	3.47e-05	3	119	2	32057361
Pubmed	Retinoic acid and mouse skin morphogenesis. I. Expression pattern of retinoic acid receptor genes during hair vibrissa follicle, plantar, and nasal gland development.	RARB RARG	3.47e-05	3	119	2	8027572
Pubmed	Cloning of murine alpha and beta retinoic acid receptors and a novel receptor gamma predominantly expressed in skin.	RARB RARG	3.47e-05	3	119	2	2544807
Pubmed	[Genetic expression and morphogenesis of the skin in vertebrates].	RARB RARG	3.47e-05	3	119	2	8099268
Pubmed	Genetic mutations associated with lung cancer metastasis to the brain.	NFE2L2 EP300	3.47e-05	3	119	2	29474635
Pubmed	Characterization of retinoic acid receptor-deficient keratinocytes.	RARB RARG	3.47e-05	3	119	2	10748128
Pubmed	Strain difference and mode of inheritance of the susceptibility to passive cutaneous anaphylaxis mediated by allogeneic IgE antibody in the mouse.	RARB RARG	3.47e-05	3	119	2	2737701
Pubmed	Multiple sites of Hox-7 expression during mouse embryogenesis: comparison with retinoic acid receptor mRNA localization.	RARB RARG	3.47e-05	3	119	2	1353971
Pubmed	Combinatorial knockout of RARα, RARβ, and RARγ completely abrogates transcriptional responses to retinoic acid in murine embryonic stem cells.	RARB RARG	3.47e-05	3	119	2	29848550
Pubmed	Polymorphisms in Vitamin A-Related Genes and Their Functions in Autoimmune Thyroid Disease.	RARB RARG	3.47e-05	3	119	2	34470463
Pubmed	A redundant oncogenic potential of the retinoic receptor (RAR) alpha, beta and gamma isoforms in acute promyelocytic leukemia.	RARB RARG	3.47e-05	3	119	2	17252005
Pubmed	Retinoic acid down-regulation of fibronectin and retinoic acid receptor alpha proteins in NIH-3T3 cells. Blocks of this response by ras transformation.	RARB RARG	3.47e-05	3	119	2	8626453
Pubmed	Function of retinoic acid receptor gamma in the mouse.	RARB RARG	3.47e-05	3	119	2	8388780
Pubmed	Retinoids and vertebrate development.	RARB RARG	3.47e-05	3	119	2	7910825
Pubmed	Tissue-specific expression of retinoic acid receptor isoform transcripts in the mouse embryo.	RARB RARG	3.47e-05	3	119	2	10842077
Pubmed	Retinoid receptors in gastric cancer: expression and influence on prognosis.	RARB RARG	3.47e-05	3	119	2	22901127
Pubmed	Both retinoic acid receptors alpha (RARalpha) and gamma (RARgamma) are able to initiate mouse upper-lip skin glandular metaplasia.	RARB RARG	3.47e-05	3	119	2	9699718
Pubmed	Acetylation of Sirt2 by p300 attenuates its deacetylase activity.	SIRT2 EP300	3.47e-05	3	119	2	18722353
Pubmed	Association of retinoic acid receptor genes with meningomyelocele.	RARB RARG	3.47e-05	3	119	2	21254357
Pubmed	Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2D.	FAT1 KMT2D	3.47e-05	3	119	2	31123786
Pubmed	Arg278, but not Lys229 or Lys236, plays an important role in the binding of retinoic acid by retinoic acid receptor gamma.	RARB RARG	3.47e-05	3	119	2	9852056
Pubmed	Retinoic acid receptors beta and gamma do not repress, but instead activate target gene transcription in both the absence and presence of hormone ligand.	RARB RARG	3.47e-05	3	119	2	12554770
Pubmed	The molecular and genetic dissection of the retinoid signalling pathway.	RARB RARG	3.47e-05	3	119	2	8276261
Pubmed	Requirement of retinoic acid receptor isotypes alpha, beta, and gamma during the initial steps of neural differentiation of PCC7 cells.	RARB RARG	3.47e-05	3	119	2	15831518
Pubmed	TBX1 and Basal Cell Carcinoma: Expression and Interactions with Gli2 and Dvl2 Signaling.	DVL2 GLI2	3.47e-05	3	119	2	31963474
Pubmed	Genesis and prevention of spinal neural tube defects in the curly tail mutant mouse: involvement of retinoic acid and its nuclear receptors RAR-beta and RAR-gamma.	RARB RARG	3.47e-05	3	119	2	7720576
Pubmed	Genes involved in cell adhesion and signaling: a new repertoire of retinoic acid receptor target genes in mouse embryonic fibroblasts.	RARB RARG	3.47e-05	3	119	2	24357724
Pubmed	Specificity of retinoid receptor gene expression in mouse cervical epithelia.	RARB RARG	3.47e-05	3	119	2	8156902
Pubmed	Interdigital apoptosis and downregulation of BAG-1 expression in mouse autopods.	RARB RARG	3.47e-05	3	119	2	11804787
Pubmed	Immunohistochemical localization of the retinoic Acid receptors in human prostate.	RARB RARG	3.47e-05	3	119	2	12399530
Pubmed	A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.	KMT2D EP300	3.47e-05	3	119	2	28732206
Pubmed	COBL, MKX and MYOC Are Potential Regulators of Brown Adipose Tissue Development Associated with Obesity-Related Metabolic Dysfunction in Children.	MKX COBL	3.47e-05	3	119	2	36834493
Pubmed	Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo.	UNCX GOLGA8N GOLGA8M	3.64e-05	19	119	3	17664336
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	VAPA MAPKAP1 TPR JCAD DVL2 APBA2 ADD3 ACSL3 RBSN FAM120C XRN1 PPP6R2 FAM131B AGAP3	3.65e-05	1139	119	14	36417873
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	VAPA BCORL1 PPHLN1 BCOR PNISR ESCO1 ACSL3 KMT2D TOX4 NFE2L2 NAT10 YLPM1 TAF5L KIF18B EP300	3.70e-05	1294	119	15	30804502
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	BCL9 BCOR ARHGEF11 ADD3 LATS2 YLPM1	3.78e-05	180	119	6	35198878
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAPKAP1 JCAD RBSN ZFP36L1 ELMO2 PLEKHG3 XRN1 COBL TNKS1BP1 MTCL1 TNFAIP3 AGAP3	4.14e-05	861	119	12	36931259
Pubmed	A human MAP kinase interactome.	TPR BICRA LAMB2 ARHGEF11 PNISR TOX4 COBL TNFAIP3 EP300	4.69e-05	486	119	9	20936779
Interaction	PHF21A interactions	TPR ZNF536 BCORL1 DVL2 ZMIZ1 BCOR RBM20 KMT2D TOX4 SALL2 FAM193A XRN1 TNKS1BP1	1.01e-07	343	117	13	int:PHF21A
Interaction	KLF15 interactions	MRPS18B BCORL1 BCL9 BCOR ADD3 KMT2D MRPS2 GLI2 MRTO4 EP300 RAI2	1.02e-06	290	117	11	int:KLF15
Interaction	CRX interactions	SOX10 ZNF536 BICRA BCORL1 ZMIZ1 BCL9 KMT2D GYS1 EP300 NPAS2	2.32e-06	254	117	10	int:CRX
Interaction	HDAC1 interactions	TPR ZNF536 RARB DVL2 MCM4 ZMIZ1 BCOR ESCO1 RBM20 KMT2D TOX4 OVOL1 LATS2 NFE2L2 GLI2 XRN1 MKX AFF1 TNKS1BP1 EP300	5.59e-06	1108	117	20	int:HDAC1
Interaction	RCOR1 interactions	TPR ZNF536 BCORL1 DVL2 LAMB2 BCOR RBM20 KMT2D TOX4 SALL2 FAM193A XRN1 TNKS1BP1	5.99e-06	494	117	13	int:RCOR1
Interaction	EGR2 interactions	SOX10 ZNF536 BICRA BCORL1 BCL9 BCOR KMT2D EP300	7.09e-06	171	117	8	int:EGR2
Interaction	GATA3 interactions	ZNF536 RARB BCL9 BCOR RBM20 KMT2D TOX4 EP300	1.36e-05	187	117	8	int:GATA3
Interaction	ASF1A interactions	ZNF536 BICRA BCORL1 MCM4 BCOR KMT2D SALL2 KIF18B EP300	1.50e-05	249	117	9	int:ASF1A
Interaction	HNF1B interactions	SOX10 ZNF536 BICRA BCL9 BCOR KMT2D TRIM37 EP300	1.53e-05	190	117	8	int:HNF1B
Interaction	SMG7 interactions	BCL9 BCOR RBM20 KMT2D SALL2 FAM193A FAM120C YLPM1 XRN1 TRIM37	1.71e-05	319	117	10	int:SMG7
Interaction	CNOT3 interactions	RBSN FAM120C GLI2 TNKS1BP1 TMEM131 PPP6R2 EP300 AGAP3	2.83e-05	207	117	8	int:CNOT3
Interaction	KDM1A interactions	TPR RPGRIP1L BCORL1 DVL2 ZMIZ1 BCOR ESCO1 RBM20 GPATCH2L KMT2D SALL2 FAM193A NFE2L2 PLEKHG3 XRN1 TNKS1BP1 EP300	3.03e-05	941	117	17	int:KDM1A
Interaction	TOP3B interactions	RARG RTEL1 BICRA KAT6A DVL2 SLCO4A1 LAMB2 BCL9 ARHGEF11 FAT1 SIRT2 KMT2D OVOL1 LATS2 FAM120C XRN1 COBL TNKS1BP1 TNFAIP3 ULK2 EP300 AGAP3	3.41e-05	1470	117	22	int:TOP3B
Interaction	PPP1R3A interactions	TOX4 MYPN YLPM1 ULK2 EP300	3.79e-05	65	117	5	int:PPP1R3A
Interaction	TNRC6B interactions	RPGRIP1L KAT6A FAM193A LATS2 FAM120C GLI2 XRN1 TNKS1BP1 TRIM37	4.00e-05	282	117	9	int:TNRC6B
Interaction	EN1 interactions	ZNF536 DCAF16 BCOR KMT2D TRIM37 EP300	4.41e-05	110	117	6	int:EN1
Interaction	GCM1 interactions	ZNF536 BCL9 BCOR KMT2D EP300	4.71e-05	68	117	5	int:GCM1
Interaction	ETV4 interactions	ZMIZ1 BCL9 KMT2D NFE2L2 EP300	5.06e-05	69	117	5	int:ETV4
Interaction	TBR1 interactions	ZNF536 ZMIZ1 BCL9 BCOR KMT2D EP300	5.13e-05	113	117	6	int:TBR1
Interaction	MAP2K1 interactions	TPR DVL2 MCM4 FAT1 SIRT2 HOXC5 NFE2L2 NAT10 EP300	5.38e-05	293	117	9	int:MAP2K1
Interaction	CEP85 interactions	RPGRIP1L FAM193A LATS2 FAM120C GLI2 TNKS1BP1 TRIM37	5.89e-05	169	117	7	int:CEP85
Interaction	TLE3 interactions	BCORL1 ZMIZ1 BCL9 BCOR RBM20 KMT2D FAM193A GLI2 TNKS1BP1 EP300	6.88e-05	376	117	10	int:TLE3
Interaction	SP7 interactions	ZNF536 BICRA ZMIZ1 BCL9 BCOR RBM20 KMT2D YLPM1 EP300	7.14e-05	304	117	9	int:SP7
Interaction	TLX1 interactions	ZNF536 MRPS18B KAT6A BCL9 BCOR KMT2D EP300	7.34e-05	175	117	7	int:TLX1
Interaction	DYRK1A interactions	VAPA TPR JCAD PNISR KMT2D FBN1 LATS2 GYS1 XRN1 AFF1 TNKS1BP1 EP300	8.90e-05	552	117	12	int:DYRK1A
Interaction	ING4 interactions	ASXL1 RARB KAT6A BCOR EP300	9.11e-05	78	117	5	int:ING4
Interaction	ALG13 interactions	BCL9 BCOR RBM20 KMT2D FAM120C XRN1 EP300	9.71e-05	183	117	7	int:ALG13
Interaction	FBXW11 interactions	VAPA POLR1A APBA2 MCM4 BCOR ELMO2 NFE2L2 GLI2 NAT10 COBL FAM219A	9.83e-05	473	117	11	int:FBXW11
Interaction	SOX7 interactions	BCORL1 BCOR RBM20 KMT2D EP300	1.16e-04	82	117	5	int:SOX7
Interaction	MYOD1 interactions	POLR2G BCL9 BCOR KMT2D SALL2 TAF5L EP300	1.40e-04	194	117	7	int:MYOD1
Interaction	HABP2 interactions	COL4A4 TNFAIP3 KNG1	1.46e-04	18	117	3	int:HABP2
Interaction	GSC interactions	ZNF536 BCORL1 BCL9 KMT2D EP300	1.53e-04	87	117	5	int:GSC
Interaction	EGLN3 interactions	VAPA MAPKAP1 JCAD DVL2 MCM4 DCAF16 BCOR RBM20 TMEM263 ACSL3 FAM193A ZFP36L1 GLI2 XRN1 TNKS1BP1 TMEM131 MTCL1 PPP6R2 TRIM37	1.65e-04	1296	117	19	int:EGLN3
Interaction	SOX15 interactions	MRPS18B BCL9 BCOR KMT2D MRTO4 EP300	1.74e-04	141	117	6	int:SOX15
Interaction	TLX2 interactions	MRPS18B MCM4 BCL9 BCOR KMT2D MRTO4	1.81e-04	142	117	6	int:TLX2
Interaction	CEP135 interactions	JCAD RPGRIP1L DVL2 ELMO2 GYS1 XRN1 TMEM131 ULK2	1.90e-04	272	117	8	int:CEP135
Interaction	FOXI1 interactions	ZNF536 BCL9 BCOR KMT2D EP300	1.99e-04	92	117	5	int:FOXI1
Interaction	HNRNPCL2 interactions	BCORL1 DVL2 PPHLN1 ARHGEF11 FREM2 XRN1 KIF18B AGAP3	2.00e-04	274	117	8	int:HNRNPCL2
Interaction	SAA1 interactions	COL4A4 PPHLN1 PLEKHG3 YLPM1	2.73e-04	54	117	4	int:SAA1
Cytoband	Ensembl 112 genes in cytogenetic band chr15q13	GOLGA8T APBA2 GOLGA8Q GOLGA8N GOLGA8M	6.65e-06	100	119	5	chr15q13
Cytoband	15q13.2	GOLGA8T GOLGA8Q GOLGA8N	2.18e-05	21	119	3	15q13.2
Cytoband	16q12.2	RPGRIP1L CHD9 OGFOD1	4.23e-05	26	119	3	16q12.2
Cytoband	10q25.2	RBM20 ADD3	7.81e-04	16	119	2	10q25.2
Cytoband	18p11.22	VAPA MTCL1	8.83e-04	17	119	2	18p11.22
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	ASXL1 KAT6A CHD9 ZMIZ1 PNISR FAT1 NFE2L2 AFF1 MTCL1 TAF5L NPAS2	1.30e-07	300	119	11	M8702
Coexpression	FAN_EMBRYONIC_CTX_OLIG	SOX10 ZNF536 SLCO3A1 PELI1 BCOR IFNGR1 SIRT2 FBN1 ZDHHC9 PLEKHG3 PCSK7 PACS2 COBL ULK2 FAM131B	1.72e-06	754	119	15	M39037
Coexpression	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	PELI1 NFKBIZ LATS2 ZFP36L1 MYPN COBL AFF1 TNFAIP3	1.13e-05	232	119	8	M2613
Coexpression	BILD_CTNNB1_ONCOGENIC_SIGNATURE	MAPKAP1 CHD9 PNISR LATS2 TNFAIP3	3.06e-05	79	119	5	M7102
Coexpression	GSE17721_POLYIC_VS_CPG_24H_BMDC_UP	COL4A4 DBNDD2 BCL9 ADD3 ZFP36L1 AFF1 TMEM131	3.46e-05	198	119	7	M3953
Coexpression	BENPORATH_NANOG_TARGETS	ASXL1 RARB POLR1A KAT6A DVL2 BCL9 PNISR DARS2 ADD3 FAT1 SALL2 ZFP36L1 PLEKHG3 FAM131B NPAS2	4.23e-05	988	119	15	M6616
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	KAT6A CHD9 ZMIZ1 FAT1 MTCL1 NPAS2	5.37e-05	145	119	6	M1810
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	KAT6A CHD9 ZMIZ1 PNISR ACSL3 FAT1 AFF1 TMEM131 MTCL1 TRIM37	5.42e-05	466	119	10	M13522
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMB2 ESCO1 RBSN PCSK7 TMEM131 EP300	7.66e-06	175	119	6	dbd9dac129fb6ae5f55e7b96d04b37585458dc4a
ToppCell	10x5'v1-week_17-19-Lymphocytic_NK-T_NK-ILC_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL4A4 RARG APBA2 GGTLC2 GOLGA8N TNFAIP3	8.72e-06	179	119	6	d18a520568cf4b031972d3dd7d4d4bd073ac1fea
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR KAT6A NFKBIZ CHD9 XRN1 EP300	9.59e-06	182	119	6	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR KAT6A NFKBIZ CHD9 XRN1 EP300	1.02e-05	184	119	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR KAT6A NFKBIZ CHD9 XRN1 EP300	1.05e-05	185	119	6	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	RARB SLCO4A1 SLCO3A1 PELI1 PPP6R2 NPAS2	1.22e-05	190	119	6	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SOX10 ZNF536 SLCO3A1 ADD3 PACS2 COBL	1.38e-05	194	119	6	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SOX10 ZNF536 SLCO3A1 SIRT2 ZDHHC9 PACS2	1.55e-05	198	119	6	bdabdb11217ea16e5863aa6bfb0f04d48b17f81e
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX10 ZNF536 DBNDD2 SIRT2 ZDHHC9 PACS2	1.55e-05	198	119	6	27f0654fb0857e93f030e1a4b1c307b31576bbcd
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SOX10 ZNF536 SLCO3A1 ADD3 ZDHHC9 PLEKHG3	1.59e-05	199	119	6	214a6a267e77e5508867b9eb48c4fbc7855ed0a0
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	RARB LAMB2 FAT1 FBN1 GLI2 MMRN2	1.64e-05	200	119	6	ad3fb8ef0be45032369d1325024787fbe1dfb8d6
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial\|5w / Sample Type, Dataset, Time_group, and Cell type.	JCAD RARG SLCO4A1 TMEM132C FGF23 ZFP36L1	1.64e-05	200	119	6	69707f9576d326a06faac49701ef5cd632e760f6
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX10 ADD3 ACSL3 SIRT2 ZDHHC9 PACS2	1.64e-05	200	119	6	f0c338877e39226a90c4effe12f6501d33542a73
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial-Proteoglycan-expressing_cell\|5w / Sample Type, Dataset, Time_group, and Cell type.	JCAD RARG SLCO4A1 TMEM132C FGF23 ZFP36L1	1.64e-05	200	119	6	f94381d0a3b5b81cdbb13b75fc0e4910cbd70382
ToppCell	Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Striatum / BrainAtlas - Mouse McCarroll V32	ZNF536 TMEM132C MYPN MKX CACNA1G	2.92e-05	133	119	5	d5326a6ccada5ae6d3e8f7d4a858c90050e23c5b
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	SOX10 RBM20 GYS1 AFF1 DLX3	6.43e-05	157	119	5	2c1219ee19a6246a3b9f5c2c1a37f26ea934a822
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ZNF536 TMEM132C FAT1 MTCL1 RAI2	6.43e-05	157	119	5	b9d04ee417c0d8ea0801d10f1c54e138587009fd
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZNF536 TMEM132C FGF23 FBN1 GLI2	6.43e-05	157	119	5	f147e24f2ece82e1c54750868954d09b3c461804
ToppCell	Striatum-Neuronal-Inhibitory\|Striatum / BrainAtlas - Mouse McCarroll V32	ZNF536 ADRA1B MYPN MKX CACNA1G	6.43e-05	157	119	5	c41ff3fe9de7187575114febfe9bd8733366fb8a
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TMEM132C MMRN2 CACNA1G RAI2 IL27RA	7.04e-05	160	119	5	636127753e3a22831f39d4c8170df40901e4329d
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TMEM132C MMRN2 CACNA1G RAI2 IL27RA	7.04e-05	160	119	5	cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	KAT6A PNISR PCSK7 KCNS1 TNFAIP3	7.46e-05	162	119	5	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARG TRARG1 IFNGR1 ZFP36L1 TNFAIP3	9.63e-05	171	119	5	8719a18c9e6b6f5d8ec4e937c2bda1e36441c9ec
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-BM_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARG TRARG1 IFNGR1 ZFP36L1 TNFAIP3	9.63e-05	171	119	5	f4cdd7862c8fe99ee765a2f3ed375b584f4976c5
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Activated_T\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	POLR1A ARHGAP30 RBM20 TNFAIP3 IL27RA	1.02e-04	173	119	5	7186add017271382ecafbff8ee87afb45fbfc745
ToppCell	COVID-19-Myeloid-MoAM5,_CCL3L1\|COVID-19 / Condition, Lineage and Cell class	NFKBIZ NFE2L2 TNFAIP3 ZNF697 AGAP3	1.02e-04	173	119	5	502f888b7684ed39f5c577eedcacf673ae81d39e
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	APBA2 FREM2 TNKS1BP1 MTCL1 NPAS2	1.04e-04	174	119	5	110369f6b78de34a6d934b5b47cecd023347bc80
ToppCell	droplet-Liver-LIVER-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 TMEM263 MMRN2 RAI2 ZNF697	1.10e-04	176	119	5	4d2fb51e71bed0d72f3d7f89d395744860885a5f
ToppCell	droplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 TMEM263 MMRN2 RAI2 ZNF697	1.10e-04	176	119	5	4880fa20b50eb10358e08567e08559ef2954f237
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR CHD9 ESCO1 RBM20 XRN1	1.10e-04	176	119	5	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	droplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 TMEM263 MMRN2 RAI2 ZNF697	1.10e-04	176	119	5	fcdddd949ca05b3ecde240db9e38296a6eab2d6a
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1\|TCGA-Liver / Sample_Type by Project: Shred V9	RPGRIP1L RARG DBNDD2 SLCO3A1 MTCL1	1.16e-04	178	119	5	51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RARB LAMB2 ECM1 FAT1 MMRN2	1.19e-04	179	119	5	98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09
ToppCell	renal_papilla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 RARB SLCO4A1 SLCO3A1 NPAS2	1.22e-04	180	119	5	49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR CHD9 ESCO1 ZFP36L1 XRN1	1.29e-04	182	119	5	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARG SLCO3A1 PELI1 TNFAIP3 IL27RA	1.36e-04	184	119	5	8c23945bafe8926f25836bc208115edd5214a2b0
ToppCell	10x5'v1-week_12-13-Mesenchymal_myocytic\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RARB RARG ZFP36L1 GLI2 DLX3	1.36e-04	184	119	5	437bc6c983849c1c3ff85f0dee091cf7010a4665
ToppCell	10x5'v1-week_12-13-Mesenchymal_myocytic-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RARB RARG ZFP36L1 GLI2 DLX3	1.36e-04	184	119	5	d1d5dd1701dff4eedf1cebbb9f4cd603aa0009c1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RARB SLCO3A1 TMEM132C GLI2 MKX	1.39e-04	185	119	5	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ZNF536 TMEM263 TMEM132C FBN1 RAI2	1.39e-04	185	119	5	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	facs-Skin-nan-24m-Mesenchymal\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRARG1 TMEM132C ADRA1B FBN1 MKX	1.39e-04	185	119	5	8433a337625ff8398520e223ef92bf9bb0beb14c
ToppCell	facs-Skin-nan-24m-Mesenchymal-fibroblast\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRARG1 TMEM132C ADRA1B FBN1 MKX	1.39e-04	185	119	5	049d793d043d5d434f143025de49dd210d18756c
ToppCell	facs-Skin-nan-24m-Mesenchymal-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRARG1 TMEM132C ADRA1B FBN1 MKX	1.39e-04	185	119	5	63200c42565eea596f9b00728e70e544b8d50a7f
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD NFKBIZ ZFP36L1 AFF1 TNFAIP3	1.39e-04	185	119	5	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RARB SLCO3A1 TMEM132C GLI2 MKX	1.39e-04	185	119	5	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TMEM263 BORCS8 RBSN TOX4 TNFAIP3	1.43e-04	186	119	5	ed9b1a784f67e8a297e2a10993a6d97df60581ac
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX10 ZNF536 DBNDD2 ZDHHC9 PLEKHG3	1.46e-04	187	119	5	f0de86ef25e344d9b1860ee26308877d6c25ed31
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLCO3A1 ECM1 ADRA1B FBN1 FAM131B	1.46e-04	187	119	5	0d4b7da81036c2aa678654b9fe49c939d08fcd9b
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX10 ZNF536 DBNDD2 ZDHHC9 PLEKHG3	1.46e-04	187	119	5	b71d0cd91bc98e020757c1d071a13ad48d718bcf
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD RARG ADD3 MMRN2 TRIM37	1.50e-04	188	119	5	0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	ZNF536 TMEM132C FAT1 FBN1 GLI2	1.54e-04	189	119	5	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 TRARG1 SALL2 MMRN2 TRIM37	1.54e-04	189	119	5	ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARG POLR1A ECM1 GLI2 TNKS1BP1	1.54e-04	189	119	5	38acb307907fde68b992057714448c1561d69ee3
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD RARG ADD3 MMRN2 TRIM37	1.58e-04	190	119	5	a08c5929b05a4969852e351a93c4e4deb4c8d5b6
ToppCell	Severe-MAIT\|World / Disease group and Cell class	RARG IFNGR1 LATS2 ZFP36L1 TNFAIP3	1.58e-04	190	119	5	7a92e0d6a021be23125495927b8571e25c83204a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RARB SLCO3A1 TMEM132C GLI2 NPAS2	1.58e-04	190	119	5	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD RARG ADD3 MMRN2 TRIM37	1.58e-04	190	119	5	25525fee1da8a808034d9c916159fd0b6b26bce8
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ZNF536 ECM1 TMEM263 TMEM132C FBN1	1.62e-04	191	119	5	9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPKAP1 TPR CHD9 ESCO1 NFE2L2	1.62e-04	191	119	5	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLCO3A1 DCC TMEM132C FBN1 GLI2	1.62e-04	191	119	5	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL4A4 NFKBIZ CHD9 TMEM132C FBN1	1.62e-04	191	119	5	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	COVID-19_Mild-MAIT\|COVID-19_Mild / Disease condition and Cell class	RARG NFKBIZ IFNGR1 NFE2L2 TNFAIP3	1.62e-04	191	119	5	e834d7a6aa7bb4f194b203d351e53bf5d95175d6
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPKAP1 TPR CHD9 ESCO1 NFE2L2	1.62e-04	191	119	5	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPKAP1 TPR CHD9 ESCO1 NFE2L2	1.62e-04	191	119	5	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 RARB ADRA1B FBN1 GLI2	1.65e-04	192	119	5	9093a9e94a25682d109a7f6edc256a25a61103a0
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLCO3A1 DCC TMEM132C FBN1 GLI2	1.65e-04	192	119	5	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 RARB SLCO3A1 CHD9 NPAS2	1.65e-04	192	119	5	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 RARB ADRA1B FBN1 GLI2	1.65e-04	192	119	5	9ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	LAMB2 PNISR GPATCH2L MRTO4 KIF18B	1.65e-04	192	119	5	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	PND07\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP30 TMEM132C ADRA1B FBN1 ZFP36L1	1.65e-04	192	119	5	8171a60df481195c39a7f740effcae8e4deb6ca7
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLCO3A1 DCC TMEM132C FBN1 GLI2	1.65e-04	192	119	5	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	JCAD ZNF536 MCM4 MTCL1 KIF18B	1.70e-04	193	119	5	bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SOX10 DBNDD2 SLCO3A1 SIRT2 PACS2	1.70e-04	193	119	5	947200ef6c3a2e35ad7e6b4af29d92384bdf73f5
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	COL4A4 NFKBIZ CHD9 ECM1 FBN1	1.74e-04	194	119	5	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_Cytotoxic_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NFKBIZ IFNGR1 ZFP36L1 NFE2L2 TNFAIP3	1.74e-04	194	119	5	094e8dfe640c7cca410b85f93063ea0bd7e861cf
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLCO3A1 DCC TMEM132C FBN1 GLI2	1.74e-04	194	119	5	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLCO3A1 DCC TMEM132C FBN1 GLI2	1.74e-04	194	119	5	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	LA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	COL4A4 NFKBIZ FBN1 ZDHHC9 TNFAIP3	1.74e-04	194	119	5	803fa83ceada17c38ca9f933b888f7e7b0b90761
ToppCell	10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	RARB RARG FAT1 MKX DLX3	1.78e-04	195	119	5	30ed961151b8b1f6ce37f06c9a061519f01c2864
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NFKBIZ F5 FBN1 MYPN TNFAIP3	1.78e-04	195	119	5	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NFKBIZ F5 FBN1 MYPN TNFAIP3	1.78e-04	195	119	5	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL4A4 NFKBIZ CHD9 ADD3 FBN1	1.78e-04	195	119	5	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	COL4A4 CHD9 ADD3 FBN1 NFE2L2	1.78e-04	195	119	5	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL4A4 RARB FBN1 GLI2 NPAS2	1.78e-04	195	119	5	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX10 DBNDD2 SLCO3A1 SIRT2 PACS2	1.82e-04	196	119	5	f068ce40bf35021baf1468ae9ce30a92162eb14d
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL4A4 NFKBIZ TMEM132C FBN1 NFE2L2	1.82e-04	196	119	5	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF536 DBNDD2 SIRT2 ZDHHC9 PLEKHG3	1.86e-04	197	119	5	032ccc91e604113da9bc34a6f9ddb1d45dea1892
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-E\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	LAMB2 ECM1 ADD3 FBN1 NFE2L2	1.86e-04	197	119	5	9b1c1d72c5a8c90d71ae31e4c198d2276872eaa0
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	LAMB2 NFKBIZ RBM20 ZFP36L1 NFE2L2	1.86e-04	197	119	5	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RARB LAMB2 RBM20 FAT1 DLX3	1.86e-04	197	119	5	2ca5ebb708935a90b12b8e98a22ae2d664ed002e
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SOX10 ZNF536 SLCO3A1 PACS2 COBL	1.86e-04	197	119	5	82b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAPKAP1 RARB FBN1 MKX CACNA1G	1.86e-04	197	119	5	9af431323da6d099459b7360af40e5df998cffbd
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RARB FAT1 MKX DLX3 RAI2	1.86e-04	197	119	5	2f72fd9a5b6d62c24a95ed2246194ea7458c0f12
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	LAMB2 NFKBIZ RBM20 ZFP36L1 NFE2L2	1.86e-04	197	119	5	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	NFKBIZ PNISR NFE2L2 XRN1 TNFAIP3	1.86e-04	197	119	5	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	critical-Myeloid-Neutrophil\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PELI1 NFKBIZ ZFP36L1 NFE2L2 TNFAIP3	1.86e-04	197	119	5	f1248781e71e3a158d06e9ec93eb90dc6d48bcb2
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX10 ZNF536 DBNDD2 ZDHHC9 PACS2	1.91e-04	198	119	5	a183afe4c2034323f77abfa080f359d67da35e8f
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TPR ARHGAP30 ADD3 XRN1 PCSK7	1.91e-04	198	119	5	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	COVID-19_Severe-Neu_1\|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients	NFKBIZ F5 ZFP36L1 NFE2L2 TNFAIP3	1.91e-04	198	119	5	bbe639ea5a636c985e509fb0a133ae3b60afac5a
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-IN_Progenitors\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	LAMB2 ADD3 FAT1 ZFP36L1 NFE2L2	1.91e-04	198	119	5	3811d9e3e54bbe8b208c591697e43b55ab5bbf0e
Computational	Neighborhood of MAP1B	ACSL3 ELMO2 ULK2 TRIM37 FAM219A	7.08e-05	65	72	5	GCM_MAP1B
Drug	Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A	RTEL1 KAT6A DVL2 APBA2 FGF23 BORCS8 OVOL1 FAM120C	7.79e-06	197	116	8	6010_DN
Drug	Tiletamine hydrochloride; Up 200; 15.4uM; PC3; HT_HG-U133A	TPR RPGRIP1L BORCS8 ZFP36L1 PLEKHG3 AFF1 TAF5L PPP6R2	7.79e-06	197	116	8	7311_UP
Drug	Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	RARG RTEL1 KAT6A APBA2 PELI1 FAM120C PPP6R2 ULK2	8.09e-06	198	116	8	5028_DN
Drug	Pentoxifylline [6493-05-6]; Up 200; 14.4uM; PC3; HT_HG-U133A	BCORL1 DVL2 ARHGEF11 PNISR PCSK7 COBL TNFAIP3 RAI2	8.70e-06	200	116	8	2127_UP
Drug	4-carboxyphenylretinamide	RARB RARG	2.57e-05	2	116	2	CID006439748
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	ASXL1 KAT6A CHD9 ZMIZ1 NFE2L2 MTCL1 EP300	3.88e-05	180	116	7	4541_DN
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	TPR BCORL1 MCM4 DCAF16 TOX4 YLPM1 ULK2	4.78e-05	186	116	7	3279_DN
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; HL60; HG-U133A	RTEL1 IFNGR1 SALL2 ELMO2 YLPM1 PCSK7 TNFAIP3	5.11e-05	188	116	7	1395_UP
Drug	Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A	RARG KAT6A FGF23 SALL2 AFF1 MTCL1 TNFAIP3	5.65e-05	191	116	7	6236_UP
Drug	Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A	RARG BICRA MCM4 BORCS8 FAM120C KCNS1 TAF5L	5.84e-05	192	116	7	4496_DN
Drug	Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	RARG DVL2 MCM4 FGF23 YIF1B FAM120C ELMO2	5.84e-05	192	116	7	3753_DN
Drug	Triflupromazine hydrochloride [1098-60-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	RARG RTEL1 KAT6A DVL2 BCL9 PCSK7 PPP6R2	5.84e-05	192	116	7	7466_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A	RARG KAT6A TOX4 FBN1 PLEKHG3 ULK2 NPAS2	5.84e-05	192	116	7	5058_DN
Drug	2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A	RPGRIP1L BCORL1 PELI1 SALL2 YIF1B RAI2 NPAS2	6.03e-05	193	116	7	5600_UP
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A	TPR SOX10 ECM1 HOXC5 FBN1 PLEKHG3 TNFAIP3	6.03e-05	193	116	7	6400_DN
Drug	Imidurea [39236-46-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A	RARB DCC FBN1 FAM120C MMRN2 KCNS1 MAGEC1	6.44e-05	195	116	7	3522_UP
Drug	valinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A	BCL9 BORCS8 FAM120C YLPM1 COBL MTCL1 TNFAIP3	6.44e-05	195	116	7	5911_DN
Drug	Dosulepin hydrochloride [897-15-4]; Up 200; 12uM; HL60; HG-U133A	APBA2 SLCO4A1 ADD3 SALL2 ELMO2 YLPM1 PCSK7	6.65e-05	196	116	7	1713_UP
Drug	Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; PC3; HT_HG-U133A	SOX10 RTEL1 FGF23 HOXC5 GLI2 MMRN2 AFF1	6.65e-05	196	116	7	5088_UP
Drug	Sulfaguanidine [57-67-0]; Up 200; 18.6uM; PC3; HG-U133A	RARG RTEL1 BCORL1 ARHGEF11 PNISR TOX4 PCSK7	6.65e-05	196	116	7	1913_UP
Drug	genistein; Down 200; 10uM; PC3; HT_HG-U133A	RARG DVL2 APBA2 SLCO3A1 HOXC5 KCNS1 FAM131B	6.87e-05	197	116	7	4459_DN
Drug	AG-013608 [351320-38-2]; Up 200; 10uM; PC3; HT_HG-U133A	RARG ECM1 HOXC5 FAM120C GLI2 TNFAIP3 IL27RA	6.87e-05	197	116	7	5949_UP
Drug	0393-0188; Down 200; 10uM; PC3; HT_HG-U133A	RARG DVL2 MCM4 DARS2 BORCS8 YIF1B KCNS1	6.87e-05	197	116	7	7510_DN
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	TPR JCAD RPGRIP1L BORCS8 FAM120C ELMO2 NPAS2	6.87e-05	197	116	7	3748_DN
Drug	Austricine [10180-88-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A	SOX10 RTEL1 BCORL1 APBA2 BORCS8 FBN1 RAI2	6.87e-05	197	116	7	4797_UP
Drug	Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; PC3; HT_HG-U133A	RARG RTEL1 MCM4 BORCS8 FBN1 ELMO2 PCSK7	7.32e-05	199	116	7	4615_DN
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	RARG KAT6A DVL2 ELMO2 YLPM1 KCNS1 PPP6R2	7.32e-05	199	116	7	2322_DN
Drug	AGN 190299	RARB RARG	7.69e-05	3	116	2	ctd:C090766
Drug	3-((4,6-diphenoxy-1,3,5-triazin-2-yl)amino)benzoic acid	RARB RARG	7.69e-05	3	116	2	ctd:C529372
Disease	colorectal cancer (is_implicated_in)	PELI1 DCC BCOR FAT1 TNFAIP3 EP300	7.04e-06	121	112	6	DOID:9256 (is_implicated_in)
Disease	Adenoid Cystic Carcinoma	KAT6A BCORL1 BCOR FAT1 EP300	4.07e-05	100	112	5	C0010606
Disease	macula measurement	COL4A4 RARB FAT1 FBN1 YLPM1 COBL	8.69e-05	189	112	6	EFO_0008375
Disease	mood instability measurement	RARB LAMB2 DCC YLPM1 EP300	1.31e-04	128	112	5	EFO_0008475
Disease	lung small cell carcinoma (is_implicated_in)	RARB FAT1 KMT2D	1.63e-04	28	112	3	DOID:5409 (is_implicated_in)
Disease	Liver Cirrhosis, Experimental	DBNDD2 NFKBIZ ARHGAP30 ADD3 IFNGR1 ADRA1B FAT1 FBN1 NFE2L2 KNG1 NPAS2	1.79e-04	774	112	11	C0023893
Disease	Neurotoxicity Syndromes	ADD3 ADRA1B NFE2L2	1.81e-04	29	112	3	C0235032
Disease	Bilateral Wilms Tumor	ASXL1 BCORL1 BCOR	1.81e-04	29	112	3	C2930471
Disease	Encephalopathy, Toxic	ADD3 ADRA1B NFE2L2	1.81e-04	29	112	3	C0149504
Disease	Toxic Encephalitis	ADD3 ADRA1B NFE2L2	1.81e-04	29	112	3	C0154659
Disease	Nephroblastoma	ASXL1 BCORL1 BCOR	3.47e-04	36	112	3	C0027708
Disease	Squamous cell carcinoma of esophagus	FAT1 KMT2D NFE2L2 EP300	4.80e-04	95	112	4	C0279626
Disease	mean platelet volume	JCAD BCORL1 CHD9 ZMIZ1 BCOR ACSL3 TOX4 YIF1B ZFP36L1 AFF1 KCNS1 ULK2	5.05e-04	1020	112	12	EFO_0004584
Disease	PR interval	RARB LAMB2 PPHLN1 ZMIZ1 FREM2 FAT1 AFF1 CACNA1G	6.15e-04	495	112	8	EFO_0004462
Disease	cup-to-disc ratio measurement, optic cup area measurement, optic disc area measurement	RARB PLEKHG3	6.30e-04	10	112	2	EFO_0006937, EFO_0006939, EFO_0006940
Disease	membranoproliferative glomerulonephritis (implicated_via_orthology)	F5 EP300	6.30e-04	10	112	2	DOID:2920 (implicated_via_orthology)
Disease	esophagus squamous cell carcinoma (is_implicated_in)	DCC FAT1 KMT2D	6.73e-04	45	112	3	DOID:3748 (is_implicated_in)
Disease	Acute Promyelocytic Leukemia	ASXL1 BCOR GLI2	7.18e-04	46	112	3	C0023487
Disease	gastric adenocarcinoma (is_implicated_in)	RTEL1 KMT2D	7.68e-04	11	112	2	DOID:3717 (is_implicated_in)
Disease	FEV/FEC ratio	VAPA JCAD ASXL1 RARB DCC GPATCH2L ADD3 FREM2 HOXC5 FBN1 YLPM1 MTCL1 AGAP3	7.87e-04	1228	112	13	EFO_0004713
Disease	forced expiratory volume	VAPA JCAD RARB DCC BCL9 RBM20 MYPN AFF1 MTCL1 PPP6R2	8.60e-04	789	112	10	EFO_0004314
Disease	triglyceride measurement, intermediate density lipoprotein measurement	DNAH10 PCSK7 AFF1 PPP6R2	8.62e-04	111	112	4	EFO_0004530, EFO_0008595
Disease	esophageal cancer (is_implicated_in)	DCC TNFAIP3	1.08e-03	13	112	2	DOID:5041 (is_implicated_in)
Disease	Proteinuria	RARB FAM151B	1.45e-03	15	112	2	HP_0000093
Disease	Lymphoma, Follicular, Grade 2	KMT2D TNFAIP3	1.45e-03	15	112	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	KMT2D TNFAIP3	1.45e-03	15	112	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	KMT2D TNFAIP3	1.45e-03	15	112	2	C1956130
Disease	Lymphoma, Large-Cell, Follicular	KMT2D TNFAIP3	1.45e-03	15	112	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	KMT2D TNFAIP3	1.45e-03	15	112	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	KMT2D TNFAIP3	1.45e-03	15	112	2	C0079758
Disease	hematocrit	JCAD UNCX TRARG1 RTEL1 BCORL1 GPATCH2L DARS2 ADRA1B FAT1 ZFP36L1 AFF1	1.63e-03	1011	112	11	EFO_0004348
Disease	psoriasis vulgaris	NFKBIZ ZMIZ1 TNFAIP3	1.63e-03	61	112	3	EFO_1001494
Disease	T-Cell Lymphoma	KMT2D EP300	1.65e-03	16	112	2	C0079772
Disease	diabetic retinopathy (implicated_via_orthology)	NFE2L2 EP300	1.65e-03	16	112	2	DOID:8947 (implicated_via_orthology)
Disease	triacylglycerol 56:9 measurement	BCOR MAGEC1	1.87e-03	17	112	2	EFO_0010436
Disease	Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism	F5 KNG1	1.87e-03	17	112	2	EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140
Disease	Tourette syndrome, schizophrenia	ZNF536 DNAH10	2.10e-03	18	112	2	EFO_0004895, MONDO_0005090
Disease	venous thromboembolism, fibrinogen measurement	CHD9 F5 ZFP36L1	2.14e-03	67	112	3	EFO_0004286, EFO_0004623
Disease	triglycerides to phosphoglycerides ratio	DNAH10 PCSK7 AFF1	2.23e-03	68	112	3	EFO_0022327
Disease	respiratory system disease	RTEL1 OVOL1 ZFP36L1 TNFAIP3	2.30e-03	145	112	4	EFO_0000684
Disease	hair colour measurement	ASXL1 APBA2 ZMIZ1 ADD3 FREM2 KMT2D OVOL1 ZFP36L1	2.43e-03	615	112	8	EFO_0007822
Disease	vital capacity	RARB RARG ZMIZ1 DCAF16 DCC RBM20 IFNGR1 MYPN AFF1 MTCL1 PPP6R2 AGAP3	2.59e-03	1236	112	12	EFO_0004312
Disease	coagulation factor V measurement	F5 DLX3	2.59e-03	20	112	2	EFO_0008087
Disease	Lymphoma, Follicular	KMT2D TNFAIP3	2.59e-03	20	112	2	C0024301
Disease	parental longevity	MAPKAP1 JCAD RARB BICRA LAMB2 DCC YLPM1	2.83e-03	494	112	7	EFO_0007796
Disease	esophagus squamous cell carcinoma (is_marker_for)	FAT1 KMT2D TNFAIP3	2.84e-03	74	112	3	DOID:3748 (is_marker_for)
Disease	psoriasis, type 2 diabetes mellitus	NFKBIZ ZMIZ1 TNFAIP3	2.95e-03	75	112	3	EFO_0000676, MONDO_0005148
Disease	peak expiratory flow	VAPA JCAD RARB MYPN XRN1 MTCL1 PPP6R2	2.96e-03	498	112	7	EFO_0009718
Disease	testosterone measurement	ZNF536 POLR1A BCORL1 ZMIZ1 DCAF16 OVOL1 ZFP36L1 NFE2L2 GYS1 MYPN AFF1 TNKS1BP1	3.33e-03	1275	112	12	EFO_0004908
Disease	partial thromboplastin time	F5 KNG1	3.73e-03	24	112	2	EFO_0004310
Disease	Cancer of Head	RARB FAT1	3.73e-03	24	112	2	C0751177
Disease	triacylglycerol 56:4 measurement	DCAF16 MAGEC1	3.73e-03	24	112	2	EFO_0010431
Disease	Head Neoplasms	RARB FAT1	3.73e-03	24	112	2	C0018675
Disease	Upper Aerodigestive Tract Neoplasms	RARB FAT1	3.73e-03	24	112	2	C0887900

Protein segments in the cluster

Peptide	Gene	Start	Entry
DGPMPKPHSVSLNDT	VAPA	156	Q9P0L0
SEATTSLPPGMQHPA	AGAP3	506	Q96P47
SPHPGLVAAQANPME	EP300	2346	Q09472
STMQFEDDDHGPPAP	ADD3	536	Q9UEY8
HNPPGSSDQEGDDPM	BCORL1	1651	Q5H9F3
DSSTDHSEAPMSPPQ	ARHGEF11	1371	O15085
HSQTDQEPTCPLGMP	COL4A4	1471	P53420
MNPDLDTGHNTSAPA	ADRA1B	1	P35368
GPVPHSQEPESEDME	APBA2	21	Q99767
PADQVASDMPHSPTL	BCOR	1116	Q6W2J9
GEVPLEHSPNNSDSM	DLX3	191	O60479
NPTPMEPTSPGEHQQ	FAM193A	1121	P78312
MGPRNPSPDHLSESE	DCAF16	1	Q9NXF7
SSDNPQPEMAPPVHE	DVL2	91	O14641
VLPPAHDDSMSESPQ	ASXL1	1121	Q8IXJ9
DAATEMLSQPNHPSG	RAI2	406	Q9Y5P3
AMSQDADPSGPEQPD	RBM20	6	Q5T481
LPQSSMPQQHEGPSL	RBSN	611	Q9H1K0
MPQQHEGPSLNPFDE	RBSN	616	Q9H1K0
QEMLENSEGHEPLTP	RARB	411	P10826
MFEDDSSQPGPHPNA	RARG	421	P13631
HSLGDTAEPGPMENQ	MTCL1	1881	Q9Y4B5
DAHPANSSSAPMPVL	NPAS2	716	Q99743
SNQFESIHPPRDMPA	FAT1	4456	Q14517
SPPQMHSSAIPLDFD	MCM4	71	P33991
ESPEDMPAGQTPHTV	MCM4	356	P33991
GTSHSPPEPENNQMA	OGFOD1	391	Q8N543
PMLPPSQPEHSSSEE	DCC	1311	P43146
PPAPSNSLHGVDMAA	HOXC5	51	Q00444
PQTPTPGESMEDVHL	NFKBIZ	191	Q9BYH8
PPEGMHSQSPLQSPE	MAGEC1	666	O60732
HLDSEGEEAPQPMPS	GOLGA8T	431	H3BQL2
MPHQSDETSPPPEDR	RPGRIP1L	981	Q68CZ1
PTISHPMDTSNFDPV	LATS2	991	Q9NRM7
MAIPEPADPGDSHQE	MMRN2	136	Q9H8L6
SPVTAQEPAHGGMQP	JCAD	456	Q9P266
SSSEPMVPPQSHHND	FREM2	3151	Q5SZK8
SNDPDPMPHPDVENG	PCSK7	211	Q16549
SEDGENPPRTHMNEG	MKX	166	Q8IYA7
PVHSSGDMVQPLSPS	NFE2L2	396	Q16236
PTAHSEMQPLDPAAA	FAM219A	11	Q8IW50
QPIMAHPPETNSDNT	FAM151B	71	Q6UXP7
HLDSEGEEAPQPMPS	GOLGA8Q	431	H3BV12
PANSSSGQPHMEQVP	IL27RA	561	Q6UWB1
NIDPMDPDACDPHTG	LAMB2	991	P55268
GHPQQTEVAPDPTTM	GLI2	1281	P10070
GQDGQPPSHADHTPM	GGTLC2	116	Q14390
DLESQAPSEPPHPQM	KCNS1	511	Q96KK3
SQPIDHEDSTMQAGP	PACS2	176	Q86VP3
TQMPEQNPTHALPES	KIF18B	466	Q86Y91
SHVATMEALPPQTPD	NAT10	211	Q9H0A0
DDSQPSLHEMGPSQP	FAM131B	226	Q86XD5
QLPSEDMGHLTDPQS	OVOL1	81	O14753
PSHPLAGTPQAQATM	KAT6A	1796	Q92794
PVHMNFPDPVDSGTQ	CHD9	356	Q3L8U1
ALESNMQPHPTELPG	CACNA1G	2016	O43497
NHINPAMDFTQTPPG	ELMO2	356	Q96JJ3
EDPPPTPQSSGMDNH	DBNDD2	181	Q9BQY9
NPEPPVSGEMDDNSL	FBN1	2696	P35555
PSAEDNSPMASDPLG	FGF23	211	Q9GZV9
TEPFSDGINMPHSLP	BCL9	531	O00512
PQDAMIPHGDTDAIP	COBL	526	O75128
QSILEGVNMNHPPPS	FAM120C	891	Q9NX05
MNASAQGHSPEEPPP	BORCS8	101	Q96FH0
LSQDTPSHAMPPQDI	MS4A14	386	Q96JA4
HMDAVEPTTPASQAP	GPATCH2L	431	Q9NWQ4
TVSPPHTSMAPAQDE	KNG1	401	P01042
PSDPPLDNQMKHSFD	ESCO1	491	Q5FWF5
PMDHPDSSQHGPPFE	ECM1	56	Q16610
PPVCTHNMLDDSSDP	GYS1	441	P13807
TGQMNGTVDHPPPAA	BICRA	1356	Q9NZM4
SNSSEHESDLPPMPG	DNAH10	171	Q8IVF4
PRPEGHNNPQVMDTE	SALL2	81	Q9Y467
VPPVRNTEMDHDGTP	PPHLN1	351	Q8NEY8
LSPATVPGMHTEDNP	IFNGR1	326	P15260
PQPAASLPDNTMVTH	PPP6R2	431	O75170
SLDPGPLEQFPHSME	MRTO4	136	Q9UKD2
MFSPDQENHPSKAPV	PELI1	1	Q96FA3
HSSEMEEVAPQPPQP	ARHGAP30	881	Q7Z6I6
HPEFSADSPSPGLNM	RTEL1	296	Q9NZ71
SRSENNGLEPPDMPS	TAF5L	216	O75529
HDLMSNTPDSVPPEE	DARS2	611	Q6PI48
MTQPPDEDTHSSFPD	TRIM37	931	O94972
PTHSQEPQGPEAMER	POLR1A	1486	O95602
PQSLPPHSEPAMESE	SLCO3A1	286	Q9UIG8
LESMGDAPPPQDEHT	TMEM132C	981	Q8N3T6
PIQDPDQMHSTSDPS	F5	1131	P12259
AQEHSPPKPSSAGEM	PLEKHG3	996	A1L390
HLDSEGEEAPQPMPS	GOLGA8M	431	H3BSY2
IHPPSMPGDSGSEIQ	MAPKAP1	41	Q9BPZ7
MAEPDPSHPLETQAG	SIRT2	1	Q8IXJ6
DQGPAHPPGADMSHS	MRPS2	281	Q9Y399
PNSAMENGLDHTPPS	SLCO4A1	16	Q96BD0
NDEPPEGSMKDHPQQ	TMEM263	16	Q8WUH6
PMDGQDQAPSESPEL	AFF1	296	P51825
ASMENQPHSKPLPSD	ACSL3	266	O95573
QGHLQEESGPPPESM	MRPS18B	221	Q9Y676
PHMFDSPPSPQDSLS	ZFP36L1	286	Q07352
PVSQPGMADPHQLFD	YIF1B	26	Q5BJH7
PAPTEHLNSNEMPED	ZDHHC9	326	Q9Y397
EGHAQNPMEPSVPQL	TNFAIP3	366	P21580
HSIPSEMEFDPNSNP	POLR2G	111	P62487
FGPPEDMPQTSSSHS	TPR	2166	P12270
SSSLEPHPADPGMET	TNKS1BP1	1416	Q9C0C2
LMGTENSPAPHAPST	TMEM131	1831	Q92545
SPMSDGNPEHPSGQS	SOX10	221	P56693
PPSEEHLSPQSFAMG	XRN1	1341	Q8IZH2
MHSTDGPLDPEPLST	nan	196	Q6ZWC4
SEPQMADHLPPQESR	YLPM1	1481	P49750
GHPEPEMGSNPQDSR	ZNF697	51	Q5TEC3
PLSGQPPNQDHKDEM	ZNF536	811	O15090
SPPSLPDMQHIQEEN	ULK2	306	Q8IYT8
PDMQHIQEENLSSPP	ULK2	311	Q8IYT8
SPSPVPQEEHSDPEM	PNISR	311	Q8TF01
MECESPEPHPLQDNG	ZBED9	176	Q6R2W3
MAHPVQSEFPSAQEP	TRARG1	1	Q8IXB3
MPSPATQLGNHDSDP	ZSCAN5C	26	A6NGD5
PERPMNNSPEAHTVE	TOX4	516	O94842
PMQETMPHAGSSDQP	ZMIZ1	941	Q9ULJ6
NSHPTTCSGEPMDPE	UNCX	176	A6NJT0
HLDSEGEEAPQPMPS	GOLGA8IP	431	A6NC78
HLDSEGEEAPQPMPS	GOLGA8N	431	F8WBI6
PAQAMSLPHEGSSPS	KMT2D	3291	O14686
PTPPHNQTEDVRMES	KMT2D	4681	O14686
SPDQMKHSPNLSFEP	MYPN	101	Q86TC9